Press release
Linneo Health launches portfolio of industrial medicinal cannabis derivatives and completes first shipments to European markets
Launch marks major expansion of company’s medicinal cannabis offering, alongside existing expertise in cultivation and delivery of cannabis flowers to
Linneo Health expands access to renewable energy by strengthening connection to Spanish national grid as part of major carbon reduction programme
European operations centre and cultivation facilities in Southern Spain decomission on-site generators and connect more efficiently to electricity gridLinneo taps
The Growing Need for Medicinal Cannabis is a Reality in Spain That Cannot be Avoided
Ahead of the snap Spanish election this weekend, Chief Executive Officer of Linneo Health Don Bellamy lays out the frustrating situation for
Linneo Health launches high THC content medicinal cannabis varieties into major global markets
New 22% and 25% THC content medicinal cannabis strains have been shipped to customers in Germany and the UK, two
Linneo Health awarded EU Good Manufacturing Practice (GMP) Part I license
Certification further expands existing offering, enabling Linneo Health to manufacture finished dosage forms alongside dried flowers and APIs Madrid, Spain,
Linneo Health expands medicinal cannabis offering to include industrial cannabis derivatives, following the issuing of EU-GMP certification to Alcaliber´s industrial facility
Linneo Health to expand offering of medicinal cannabis products to include APIs and cannabis extracts, under the terms of a